Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV

S Bjerrum, I Schiller, N Dendukuri… - Cochrane Database …, 2019 - cochranelibrary.com
Background The lateral flow urine lipoarabinomannan (LF‐LAM) assay Alere Determine™
TB LAM Ag is recommended by the World Health Organization (WHO) to help detect active …

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study

KP Reddy, FM Shebl, JHA Foote, G Harling… - The Lancet Global …, 2021 - thelancet.com
Background Health-care resource constraints in low-income and middle-income countries
necessitate the identification of cost-effective public health interventions to address COVID …

Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review

H Alsdurf, B Empringham, C Miller, A Zwerling - BMC infectious diseases, 2021 - Springer
Background Systematic screening for active tuberculosis (TB) is a strategy which requires
the health system to seek out individuals, rather than waiting for individuals to self-present …

Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study

H Huerga, M Bastard, AV Lubega, M Akinyi… - The Lancet Global …, 2023 - thelancet.com
Background Development of rapid biomarker-based tests that can diagnose tuberculosis
using non-sputum samples is a priority for tuberculosis control. We aimed to compare the …

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa

KP Reddy, KP Fitzmaurice, JA Scott, G Harling… - Nature …, 2021 - nature.com
Low-and middle-income countries are implementing COVID-19 vaccination strategies in
light of varying vaccine efficacies and costs, supply shortages, and resource constraints …

Costing the implementation of public health interventions in resource-limited settings: a conceptual framework

H Sohn, A Tucker, O Ferguson, I Gomes… - Implementation …, 2020 - Springer
Background Failing to account for the resources required to successfully implement public
health interventions can lead to an underestimation of costs and budget impact, optimistic …

Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis

EE Freeman, NC McCann, A Semeere… - The Lancet Global …, 2022 - thelancet.com
Background The most effective treatment for advanced AIDS-associated Kaposi sarcoma is
paclitaxel or pegylated liposomal doxorubicin (PLD); neither is routinely used in sub …

Addressing TB-related mortality in adults living with HIV: a review of the challenges and potential solutions

A Sullivan, RR Nathavitharana - Therapeutic Advances in …, 2022 - journals.sagepub.com
Tuberculosis (TB) is the leading cause of death in people living with HIV (PLHIV) globally,
causing 208,000 deaths in PLHIV in 2019. PLHIV have an 18-fold higher risk of TB, and …

Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual …

A Dhana, Y Hamada, AP Kengne, AD Kerkhoff… - Journal of Infection, 2022 - Elsevier
Background WHO recommends urine lateral-flow lipoarabinomannan (LF-LAM) testing with
AlereLAM in HIV-positive inpatients only if screening criteria are met. We assessed the …

Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting–A cost …

G Fekadu, Y Wang, JHS You - Plos one, 2023 - journals.plos.org
Background Recent clinical findings reported the reduced mortality associated with
treatment guided by sputum-based molecular test with urine-based lipoarabinomannan …